Status:
RECRUITING
Wuhan High Myopia Study
Lead Sponsor:
Renmin Hospital of Wuhan University
Conditions:
High Myopia
Eligibility:
All Genders
18-65 years
Brief Summary
The study aims to observe the long-term changes of ocular（especially fundus） structure and visual function in patients with high myopia, so as to provide evidence for the prevention, diagnosis and pro...
Detailed Description
High myopia is defined as a refractive error of ≤-6.00D or an axial length greater than 26mm. In recent years, the population of highly myopic individuals has been increasing rapidly. Scholars predict...
Eligibility Criteria
Inclusion
- Voluntarily sign informed consent;
- Commit to follow the research procedures and cooperate with the whole process of the study;
- Age ≥18 years old;
- Best corrected visual acuity ≥0.1;
- Spherical Equivalent Refraction≤-6.00D or axial length ≥26mm in high myopia group；
Exclusion
- Unable or unwilling to sign informed consent;
- Unable to cooperate with the examination;
- Astigmatism ≤-1.5D；
- Patients with refractive interstitial opacity so that fundus images cannot be collected；
- Patients with fundus diseases such as diabetic retinopathy, hypertensive retinopathy, age-related macular degeneration, retinal vein obstruction, retinal artery obstruction, etc
Key Trial Info
Start Date :
December 25 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2027
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06162234
Start Date
December 25 2023
End Date
September 1 2027
Last Update
December 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renmin Hospital of Wuhan University
Wuhan, Hubei, China, 430060